Corporate News Earnings summary: AbbVie reports mixed Q2 results; raises FY24 EPS outlook by Contributor since / Followers 4 months ago More on AbbVie: AbbVie Non-GAAP EPS of $2.65 misses by $0.01, revenue of $14.46B beats by $430M AbbVie: Why I Sold My Shares At $175 Cerevel Therapeutics gains as investors appear more confident on FTC approval for AbbVie Tags: ABBV Continue Reading Previous Lucid, Graphite One enter supply deal for EV battery-ready anode materialNext AbbVie in charts: Skyrizi, Rinvoq sales jump, while Humira revenue falls ~30% Y/Y in Q2
